Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

A Preview Of Oncolytics Biotech's Earnings

Oncolytics Biotech (NASDAQ:ONCY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oncolytics Biotech will report an earnings per share (EPS) of $-0.11.

Benzinga

Preview: Corcept Therapeutics's Earnings

Corcept Therapeutics (NASDAQ:CORT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Corcept Therapeutics will report an earnings per share (EPS) of $0.24.

Benzinga

A Preview Of Mirum Pharmaceuticals's Earnings

Mirum Pharmaceuticals (NASDAQ:MIRM) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Mirum Pharmaceuticals will report an earnings per share (EPS) of $-1.34.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Selecta Biosciences

Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Selecta Biosciences will report an earnings per share (EPS) of $-0.11.

Benzinga

Akoya Biosciences Earnings Preview

Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.39.

Benzinga

Check Out What Whales Are Doing With BYND

Someone with a lot of money to spend has taken a bearish stance on Beyond Meat (NASDAQ:BYND). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Twist Bioscience's Earnings: A Preview

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Twist Bioscience will report an earnings per share (EPS) of $-1.28.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What 4 Analyst Ratings Have To Say About Paramount Global

Analysts have provided the following ratings for Paramount Global (NASDAQ:PARA) within the last quarter:

Benzinga

AMD, Micron Or Nvidia: Which Chip Stock Did This Investor Just Dump And Why?

Steve Weiss cut Micron Technology Inc (NASDAQ: MU) from his portfolio on Wednesday, citing concerns that he suggested could be plaguing the entire semiconductor industry.

Benzinga

Earnings Outlook For Franchise Group

Franchise Group (NASDAQ:FRG) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Franchise Group will report an earnings per share (EPS) of $1.09.

Benzinga

This Is What Whales Are Betting On Fortinet

Someone with a lot of money to spend has taken a bearish stance on Fortinet (NASDAQ:FTNT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Analyst Ratings for Expeditors International

Expeditors International (NASDAQ:EXPD) has observed the following analyst ratings within the last quarter:

Benzinga

What Are Whales Doing With Cassava Sciences

Someone with a lot of money to spend has taken a bullish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

How Is The Market Feeling About Prospect Capital?

Prospect Capital's (NASDAQ:PSEC) short percent of float has risen 9.4% since its last report. The company recently reported that it has 4.60 million shares sold short, which is 1.63% of all regular shares that are available for trading.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

6 Analysts Have This to Say About Macrogenics

Macrogenics (NASDAQ:MGNX) has observed the following analyst ratings within the last quarter:

Benzinga

4 Stocks Moved By Traders on 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday.

Benzinga

10 Communication Services Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

10 Information Technology Stocks With Whale Alerts In Today's Session

Benzinga

Looking At Peloton Interactive's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Peloton Interactive. Looking at options history for Peloton Interactive (NASDAQ:PTON) we detected 14 strange trades.

Benzinga

Much Wow: Largest Commercial Dogecoin Transaction Ever Buys BIG3 Basketball Team

A professional basketball league co-founded by rapper Ice Cube announced a way for fans and investors to purchase teams.

Benzinga

'I'm Just Going To Continue To Add': Why This Investor Is So Bullish On Starbucks Following Earnings

Starbucks Corp (NASDAQ: SBUX) shares have been trending lower since the start of the year, but the stock is catching some bids Wednesday after the company reported strong earnings results.

Benzinga

Earnings Preview For Intellia Therapeutics

Intellia Therapeutics (NASDAQ:NTLA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Intellia Therapeutics will report an earnings per share (EPS) of $-1.10.

Benzinga

A Preview Of Baudax Bio's Earnings

Baudax Bio (NASDAQ:BXRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Baudax Bio will report an earnings per share (EPS) of $-2.35.

Benzinga

Appian's Earnings: A Preview

Appian (NASDAQ:APPN) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Appian will report an earnings per share (EPS) of $-0.13.

1 … 618 619 620 621

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.